Severe migraine and its control: A proposal for definitions and consequences for care

Revue Neurologique 2021 Mar 30; doi: 10.1016/j.neurol.2020.11.012.  Anne Donnet  , Anne Ducros  , Françoise Radat  , Bashar Allaf  , Isabelle Chouette  , Michel Lanteri-Minet Abstract Currently many patients with severe migraine do not receive appropriate treatment and are never referred to specialist headache centres.

Mambalgin-1 pain-relieving peptide locks the hinge between α4 and α5 helices to inhibit rat acid-sensing ion channel 1a

Neuropharmacology 2021 Mar 1;185:108453. doi: 10.1016/j.neuropharm.2021.108453. Epub 2021 Jan 12. Miguel Salinas, Pascal Kessler, Dominique Douguet, Daad Sarraf, Nicolo Tonali, Robert Thai, Denis Servent, Eric Lingueglia Abstract Acid-sensing ion channels (ASICs) are proton-gated cationic channels involved in pain and other processes, underscoring the potential therapeutic value of

A retrospective observation on 105 patients with chronic cluster headache receiving indomethacin

Neurological sciences 2021 Feb 5  doi: 10.1007/s10072-021-05114-4. Online ahead of print. Anaé Monta, Sylvain Redon, Cyprien Fabre, Anne Donnet Abstract Background: Indomethacin (IMC) as a prophylactic treatment is considered to be ineffective in cluster headache (CH). However, small series suggested the interest of

Real-Life Management Pathways for Chronic Peripheral Neuropathic Pain at Tertiary Pain Clinics in France

Pain Medicine 2021 Jan 29;pnaa443. doi: 10.1093/pm/pnaa443. Online ahead of print Serge Perrot, Gisèle Pickering, Michel Lantéri-Minet, Nadine Attal Objective: Peripheral neuropathic pain (PNP) represents a major public health issue. Severe or refractory cases warrant tertiary multidisciplinary management, but little information is

Health technology assessment for the acute and preventive treatment of migraine: A position statement of the International Headache Society

Cephalalgia 2021 Jan 20;333102421989247 doi: 10.1177/0333102421989247. Online ahead of print. Hans Christoph Diener , Messoud Ashina, Isabelle Durand-Zaleski, Tobias Kurth, Michel Lantéri-Minet, Richard B Lipton, Daniel A Ollendorf, Patricia Pozo-Rosich, Cristina Tassorelli, Gisela Terwindt Abstract The Clinical Trials Subcommittee of the International Headache Society presents the first Health Technology

Effect of erenumab on functional outcomes in patients with episodic migraine in whom 2-4 preventives were not useful: results from the LIBERTY study

Journal of neurology, neurosurgery, and psychiatry 2021 Jan 5;jnnp-2020-324396  doi: 10.1136/jnnp-2020-324396. Online ahead of print. Michel Lanteri-Minet, Peter J Goadsby, Uwe Reuter, Shihua Wen, Peggy Hours-Zesiger, Michel D Ferrari, Jan Klatt Objective: To evaluate the effect of erenumab on patient-reported, functional outcomes in patients with episodic

Neuromodulation techniques for acute and preventive migraine treatment: a systematic review and meta-analysis of randomized controlled trials

The Journal of Headache and Pain 2020; 21(1): 142. Xavier Moisset, Bruno Pereira, Daniel Ciampi de Andrade, Denys Fontaine, Michel Lantéri-Minet, and Jérôme Mawet Background Several neuromodulation methods exists for migraine treatment. The aim of the present study was to

Phantom eye pain: a multicentric study in 100 patients

Acta Ophthalmologica 2020 Oct 29. Arnaud Martel , Stephanie Baillif  , Pierre Thomas , Fabien Almairac , Olivier Galatoire , Mehrad Hamedani , Denys Fontaine  , Michel Lanteri-Minet Purpose: Phantom eye syndrome (PES) is an underestimated complication of eye amputation (EA) characterized by phantom eye pain (PEP),

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial

THE LANCET Neurology Volume 19, ISSUE 10, P814-825, October 01, 2020 Wim M Mulleners, Byung-Kun Kim, Miguel J A Láinez, Michel Lanteri-Minet, Patricia Pozo-Rosich, Shufang Wang, Antje Tockhorn-Heidenreich, Sheena K Aurora, Russell M Nichols, Laura Yunes-Medina, Holland C Detke. Background Many patients who require migraine preventive treatment have not been